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Introduction: Anorexia nervosa is an eating disorder that continues to have a devastating impact on the lives of
both adolescents and adults worldwide. We present a case of persistent chronic hypokalaemia in a patient with
anorexia nervosa.
Case presentation: A 26-year-old Caucasian woman was admitted to our eating disorders unit under Section 2 of
Mental Health Act (1983) with a body mass index of 13.5kg/m2. On admission, biochemical tests highlighted
moderate hypokalaemia (3.0mmol/L). She was immediately put on two tablets of Sando-K® (potassium supplement;
potassium bicarbonate and potassium chloride twice daily. An electrocardiogram showed signs of bradycardia with
T-wave inversion in at least two chest leads. Throughout her admission, she exhibited a fluctuating potassium level
(2.5 to 5.0mmol/L). Once on the unit, she was put on Sando-K® (potassium supplement; potassium bicarbonate and
potassium chloride) but her potassium still tended to drop. On one occasion when she became normokalaemic,
supplementation was stopped and she was put on observations. After 24 hours of 1 to 1 observation by ward staff
including fluid input and output monitoring as well as search of her bedroom, she was again found to be
hypokalaemic in spite of no evidence to suggest laxative or diuretic abuse.
Conclusions: She kept reiterating to clinicians that her potassium depletion is hereditary, not associated with any
purging behaviour and for that reason long-term administration of Sando-K® (potassium supplement; potassium
bicarbonate and potassium chloride) tablet remained essential. Self-denial was continued until her planned
discharge; however, positive behavioural change was recorded whilst her blood showed normokalaemia for a
whole week until her discharge.Introduction
Anorexia nervosa (AN) is an eating disorder that con-
tinues to have a devastating impact on the lives of both
adolescents and adults worldwide. It is a psychiatric dis-
order with severe metabolic effects on the entire body and
according to Thomas Insel, Director of National Institute
of Mental Health, USA, AN is the third most common
chronic illness among adolescents; AN does not discrim-
inate on the basis of age, gender, race or class and no one
is immune [1]. AN has an average prevalence of 0.3 to 1%
in women and 0.1% in men for the diagnosis in developed
countries [2].* Correspondence: kevin.mohee@nhs.net
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in a patient with AN-binge eating/purging type according
to Diagnostic and Statistical Manual of Mental Disorders,
Fifth Edition (International Statistical Classification of
Diseases and Related Health Problems, 10th revision,
ICD10-F50.0).Case presentation
A 26-year-old Caucasian woman was admitted to our eat-
ing disorders unit under Section 2 of Mental Health Act
(1983) with a body mass index (BMI) of 13.5kg/m2 (weight
30.5kg, height 1.5m). On admission, biochemical tests
highlighted moderate hypokalaemia (3.0mmol/L). She was
immediately put on two tablets of Sando-K® (potassium
supplement; potassium bicarbonate and potassium chloride)
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leads. She had been experiencing amenorrhea for 9
months prior to admission.
On initial mental state examination, she was coopera-
tive, articulate and maintained good eye contact. She
was able to give a coherent chronological account of her
story and was fully oriented in time, place and person.
She described her mood as fine but objectively appeared
low. She denied any suicidal thoughts or plans, deliber-
ate self-harm issues and any psychotic phenomena. Fur-
thermore, she was adamant that she did not present
with any abnormal non-delusional thought processes of
either anorexic or obsessive-compulsive nature. On ad-
mission she had very limited insight into her mental
condition and was unable to recognise both physical and
psychological effects of malnutrition but accepted the
implemented meal plans.
She did not approve of her eating disorder diagnosis
but reported her symptoms were driven by weight and
shape problems and compliance with meals was not a
major issue. Her personal history began at 14-years old
when she weighed 89kg and was subsequently bullied.
She then started to restrict her diet by consuming alco-
hol as her main caloric intake and was subsequently
vomiting. At the age of 16, her weight dropped to 54kg
(BMI 23.9kg/m2). She became depressed and stopped at-
tending school. She was admitted to hospital after com-
plaining of abdominal pain. After discharge, she began
to eat very little, stopped drinking and started a job. She
entered a relationship at the age of 18. During that time,
she described herself as happy, her eating habits improved
and alcohol consumption markedly reduced. However, a
year ago, she had a miscarriage and her relationship ended
soon after. She became depressed, started experiencing
panic attacks and took an overdose of antidepressants in
conjunction with alcohol as an act of despair and inability
to cope with current stress and as a consequence of that
she began dieting again. Past psychiatric history included
diagnosis of AN (F 50.0 ICD 10) a month prior to admis-
sion, bulimia and alcohol misuse. Family history included
ischemic heart disease and strokes with no confirmed his-
tory of hypokalaemia even though she reiterated the her-
editary nature of her hypokalaemia problems. Her father
has agoraphobia and uses alcohol as a coping mechanism
for anxiety. She lived on her own in a house close to her
mother, was unemployed, consumed alcohol regularly,
smoked 8 to 10 cigarettes/day, practised vigorous exer-
cise, and abused laxatives and diuretics.
National Institute for Health and Care Excellence
(NICE) guidelines recommend that patients with AN re-
quiring in-patient treatment should be admitted to a set-
ting that can provide the skilled implementation of
refeeding with careful physical monitoring (particularly
in the first few days of refeeding), in combination withpsychosocial interventions [3]. On admission, she was
monitored for refeeding syndrome, a term which encom-
passes multiple metabolic disturbances that occur as a
result of reinstitution of nutrition to patients who are
starved or severely malnourished [4]. Her risk of refeed-
ing syndrome was assessed by the local dietician and
classified as high (BMI<16kg/m2, very little nutritional
intake for more than 10 days prior to admission, history
of alcohol abuse and pre-existing low potassium) follow-
ing guidelines of the National Institute for Clinical Ex-
cellence for Nutritional Support in Adults [5] and those
of Management of Really Sick Patients with Anorexia
Nervosa (MARSIPAN) [5,6]. The key tasks of the in-
patient medical team was to safely refeed her avoiding
refeeding syndrome caused by too rapid refeeding and at
the same time avoiding underfeeding syndrome caused
by too cautious rates of refeeding. The nutritional sup-
port was commenced at 20kcal/kg/day with a view to
increasing levels slowly to meet full requirements in 5
to 7 days.
In line with MARSIPAN recommendations 2010, phys-
ical investigations included baseline full blood count, urea
and electrolytes, phosphate, calcium, magnesium, albu-
min, C-reactive protein, liver function tests, glucose, zinc,
copper, selenium, iron profile, vitamin B12 and folate, vita-
min A/E, vitamin D, thyroid function, weight – early
morning weight and ECG. Daily urea and electrolytes,
phosphate, calcium, magnesium and ECG were performed
for 1 week then twice weekly.
After 6 months of admission, she still demonstrated
bradycardia (55 beats per minute) despite improved nutri-
tional and fluid intake. Once when she was granted leave,
she admitted binge drinking and taking diuretics. Due to
her distorted body image, fluctuating capacity for treat-
ment, poor compliance with medications, laxative and di-
uretics abuse that led to life-threatening hypokalaemia
combined with alcohol misuse, her leave was cancelled
and she was detained under Section 3 of Mental Health
Act 1983.
Throughout her admission, she exhibited a fluctuating
potassium level (2.5 to 5.0mmol/L; see Figure 1). Once on
the unit, she was put on Sando-K® (potassium supplement;
potassium bicarbonate and potassium chloride) but her
potassium level still tended to drop. On one occasion
when she became normokalaemic, supplementation was
stopped and she was put on observations. After 24 hours
of 1 to 1 observation by ward staff including fluid input
and output monitoring as well as search of her bedroom,
she was again found to be hypokalaemic in spite of no evi-
dence to suggest laxative or diuretic abuse.
She was prescribed ferrous sulphate 200mg twice daily
and an antidepressant in the form of sertraline tablet
50mg in the morning and 100mg at night. As part of her
treatment for AN she was given regular supplements:
Figure 1 Diagram showing fluctuation in potassium levels.
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pyridoxine hydrochloride, riboflavine and thiamine mono-
nitrate), Sanatogen® (vitamin supplement and Adcal D3®
(calcium carbonate and vitamin D3).
During her time on the ward, she demonstrated overall
improvement with occasional rises in her weekly BMI
far above NICE recommendations as a result of abnor-
mal fluid consumption which required implementation
of fluid monitoring charts in the longer term. Gradually
she became more insightful about her diagnosis and
compliant with her meals and her BMI reached 18. Her
management plan since admission included full meal
plan, work around management of hypokalaemia, several
psychotherapeutic interventions such as motivational
interviewing, psychoeducation, mindfulness, body image,
and relapse prevention. She appeared be hypokalaemic
despite nutritional interventions on top of taking Sando-K®
(potassium supplement; potassium bicarbonate and po-
tassium chloride) tablets. She underestimated the risks
to her own health and was ambivalent about being an
in-patient any further. She continued to deny any pur-
ging behaviours and appeared distressed and upset by
fluctuations in her potassium levels. She requested to
have her hypokalaemia investigated successfully to get
more clarity behind her persistent hypokalaemia.
Hypokalaemia is defined as a serum potassium level
below 3.5mmol/L and is commonly classified as mild
(3.1 to 3.5mmol/L), moderate (3.0 to 3.5mmol/L) and se-
vere (<2.5mmol/L) [7]. It is a disorder with a myriad of
causes and is a common finding in the general popula-
tion but commoner in the hospital population with a
prevalence of 5% [5]. Most causes of hypokalaemia are
evident from the clinical picture and routine plasma bio-
chemistry evaluations and there is little need to resort to
further more complex and expensive biochemical tests.
However, in patients for whom the cause of hypokal-
aemia is not obvious, determination of potassium and
chloride concentrations in random urine concentrationscoupled with further clinical investigations often clarify
the pathogenesis of the disturbance. If serum potassium
was severely low (<2.5mmol/L) or symptoms of severe
hypokalaemia were present (muscle weakness, syncope
or palpitations), the patient would need to be evaluated.
Multiple tests were organised to find a physical cause
for our patient’s chronic hypokalaemia. On physical exam-
ination, enlargement of parotid glands was recorded. An
ECG carried out indicated small T waves and prominent
U waves. A renal ultrasound revealed normal sonographic
appearances of both kidneys. Her 9 a.m. cortisol was nor-
mal. Fruitful areas of clinical investigations of hypokal-
aemia included estimation of potassium concentration in
the urine. In the presence of hypokalaemia, a urinary po-
tassium concentration at the level of 112mmol/L implies
increased renal excretion of potassium. This can suggest
an extrarenal defect in either potassium metabolism or
distribution [8]. Her urine chloride was very low
(<20mmol/L), urine pH was 8.28, and urinary bicarbonate
was found to be 111mmol/L indicating high possibility of
gastrointestinal losses through vomiting. These results are
consistent with hypokalaemic metabolic alkalosis second-
ary to purging. The diuretic screen was negative. Her urin-
ary amino acids were within normal range ruling out a
renal tubular disorder. Her urine was analysed for electro-
lytes, amino acids, and diuretics. Venous blood gas ana-
lysis showed metabolic alkalosis with pH 7.5, bicarbonate
of 35.1 and base excess of 11.
Diuretics remain the commonest cause of renal loss of
potassium but rarer causes such as renal tubular acidosis
often associated with autoimmune conditions such as
Sjögren’s syndrome or hereditary renal tubular disorders
such as Bartter’s or Gitelman’s syndrome needed to be
excluded [3]. Assessment of serum magnesium was crucial
because hypokalaemia and hypomagnesaemia coexist and
treatment of hypokalaemia is unlikely to be successful
without correction of the hypomagnesaemia. However,
the patient presented with a normal magnesium level.
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renal assessment, she needed special endocrine assess-
ments which included renin to aldosterone ratio (to in-
vestigate for aldosteronism), thyroid function tests (to
investigate for thyrotoxic periodic paralysis) but all ap-
peared normal. A test for amylasemia was not deemed
necessary by the Consultant biochemist because sufficient
evidence was available to explain that her persistent hypo-
kalaemia was due to purging.
She was assessed for symptoms of eating disorder on
the Eating Disorder Examination Questionnaire (EDE-Q),
obsessive compulsive symptoms on the Yale-Brown
Obsessive Compulsive Scale (Y-BOCS) and depression
on Hamilton Depression Scale on admission (BMI 13.5)
and 3 weeks prior to discharge (BMI 18.15).
Her responses to an EDE-Q on admission indicated
higher than average scores in the following test domains:
shape concern with score 14 (norms 2.1), and weight con-
cern with score 4 (norms 1.5) which went down mildly in
score to 8 and 3, retrospectively after therapy. It is worth
mentioning that on admission she presented with very
limited insight into her eating disorder overtly disap-
proving AN symptoms. The Y-BOCS implemented on
admission and prior to discharge appeared non-significant.
However a vast reduction in overall score of both Hamilton
Anxiety Scale and Hamilton Depression Scale were dem-
onstrated, going from moderate to mild. Her score in her
Hamilton Anxiety Scale decreased from 25 to 16 and her
score in the Hamilton Depression Scale decreased from
27 to 8.
Neuropsychological assessment involving evaluation of
both emotional and cognitive processes was conducted 4
weeks prior to discharge. No marked alterations were
found in performance of social cognitive tests including
perception of emotional cues on Emotion Evaluation Test,
Part 1 of The Awareness of Social Inference Test (TASIT;
score 26 out of 28), and emotional empathy assessed using
Balanced Emotional Empathy Scale (BEES; score 51,
norms 45) whereas some level of impairment in mentalis-
ing ability was elicited in her performance of the “Reading
the Mind in the Eyes” test (revised version; RME; 23 out
of 36). She scored low (38; norms ≤51 low alexithymia) on
the Toronto Alexithymia Scale (TAS-20) and was cate-
gorised as nonalexithymic. Her performance of neurocogni-
tive tests enabling assessment of her attentional switching
and working memory (Stroop task, score 2.5 minutes/2
errors; and Trail Making Test -B, TMT-B, score 55 seconds)
as well as attention per se (TMT-A, score 30 seconds)
remain unremarkable.
Conclusions
The results of the numerous investigations were ex-
plained to the patient. She continued to deny any pur-
ging behaviour. She kept reiterating to clinicians that herpotassium depletion is hereditary and for that reason
long-term administration of Sando-K® (potassium supple-
ment; potassium bicarbonate and potassium chloride) tab-
let remained essential. Self-denial was continued until her
planned discharge; however, positive behavioural change
was recorded whilst her blood showed normokalaemia for
a whole week prior to her discharge. At discharge, she was
normokalaemic therefore her potassium supplementations
were discontinued.
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